(Q34084208)

30 July 2017

1 reference

title

Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy (English)

1 reference

30 July 2017

0 references

acute coronary syndrome

1 reference

Kinlay S

1

1 reference

30 July 2017

Ganz P

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

American Journal of Cardiology

30 July 2017

published in

1 reference

30 July 2017

volume

86

1 reference

30 July 2017

issue

8B

1 reference

30 July 2017

page(s)

10J-13J; discussion 13J-14J

1 reference

Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

7 January 2021

The unstable atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Coronary plaque disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Low-density lipoprotein-independent effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Lipid lowering improves endothelial functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Nitric oxide as a signaling molecule in the vascular system: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Role of endothelial dysfunction in coronary artery disease and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Close relation of endothelial function in the human coronary and peripheral circulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Endothelial dysfunction: does it matter? Is it reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Systemic nature of endothelial dysfunction in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Endothelial dysfunction: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Nitric oxide synthase: role in the genesis of vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Contribution of nitric oxide to metabolic coronary vasodilation in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Cholesterol, cholesterol lowering, and endothelial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901334-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(00)01334-5

1 reference

30 July 2017

1 reference